Your browser doesn't support javascript.
loading
Prognostic Factor Analysis of Overall Survival in Gastric Cancer from Two Phase III Studies of Second-line Ramucirumab (REGARD and RAINBOW) Using Pooled Patient Data.
Fuchs, Charles S; Muro, Kei; Tomasek, Jiri; Van Cutsem, Eric; Cho, Jae Yong; Oh, Sang-Cheul; Safran, Howard; Bodoky, György; Chau, Ian; Shimada, Yasuhiro; Al-Batran, Salah-Eddin; Passalacqua, Rodolfo; Ohtsu, Atsushi; Emig, Michael; Ferry, David; Chandrawansa, Kumari; Hsu, Yanzhi; Sashegyi, Andreas; Liepa, Astra M; Wilke, Hansjochen.
Afiliación
  • Fuchs CS; Dana-Farber Cancer Institute, Boston, MA, USA.
  • Muro K; Department of Clinical Oncology, Aichi Cancer Center Hospital, Nagoya, Japan.
  • Tomasek J; Masaryk Memorial Cancer Institute, Faculty of Medicine, Masaryk University, Brno, Czech Republic.
  • Van Cutsem E; University Hospital Gasthuisberg Leuven and KU Leuven, Leuven, Belgium.
  • Cho JY; Gangnam Severance Hospital, Seoul, Korea.
  • Oh SC; Korea University Guro Hospital, Seoul, Korea.
  • Safran H; Oncology Research Group, Brown University, Providence, RI, USA.
  • Bodoky G; Szent László Hospital, Budapest, Hungary.
  • Chau I; Royal Marsden Hospital, London and Surrey, United Kingdom.
  • Shimada Y; Gastrointestinal Medical Oncology Division, National Cancer Center Hospital, Tokyo, Japan.
  • Al-Batran SE; Institute of Clinical Research, Universitären Centrum für Tumorerkrankungen-University Cancer Center, Frankfurt, Germany.
  • Passalacqua R; Istituti Ospitalieri di Cremona, Cremona, Italy.
  • Ohtsu A; Exploratory Oncology Research and Clinical Trial Center, National Cancer Center, Kashiwa, Japan.
  • Emig M; Lilly Deutschland GmbH, Bad Homburg, Germany.
  • Ferry D; Eli Lilly and Company, Bridgewater, NJ, USA.
  • Chandrawansa K; Eli Lilly and Company, Bridgewater, NJ, USA.
  • Hsu Y; Eli Lilly and Company, Bridgewater, NJ, USA.
  • Sashegyi A; Eli Lilly and Company, Indianapolis, IN, USA.
  • Liepa AM; Eli Lilly and Company, Indianapolis, IN, USA.
  • Wilke H; Departments of Oncology and Hematology with Integrated Palliative Care, Kliniken Essen-Mitte, Essen, Germany.
J Gastric Cancer ; 17(2): 132-144, 2017 Jun.
Article en En | MEDLINE | ID: mdl-28680718
Palabras clave
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Tipo de estudio: Clinical_trials / Prognostic_studies Aspecto: Patient_preference Idioma: En Revista: J Gastric Cancer Año: 2017 Tipo del documento: Article País de afiliación: Estados Unidos Pais de publicación:
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Tipo de estudio: Clinical_trials / Prognostic_studies Aspecto: Patient_preference Idioma: En Revista: J Gastric Cancer Año: 2017 Tipo del documento: Article País de afiliación: Estados Unidos Pais de publicación: